Jinhe Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jinhe Guo has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Qingbo Li
College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
2 shared publications- Xianbin Kong
College of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China; Tianjin Key Laboratory of Modern Chinese Medicine Theory of Innovation and Application, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
2 shared publications - Bin Lv
Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P.R. China
1 shared publication Bin Yu
School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China
1 shared publication- Chuanxin Liu
Luoyang Key Laboratory of Clinical Multiomics and Translational Medicine, Key Laboratory of Hereditary Rare Diseases of Health Commission of Henan Province, Henan Key Laboratory of Rare Diseases, Endocrinology and Metabolism Center, The First Affiliated Hospital, College of Clinical Medicine of Henan, University of Science and Technology, Luoyang, China
1 shared publication Chunyu Gu
School of Chinese Materia Medica, Beijing University of Chinese Medicine, Fangshan District, Beijing 102488, China
1 shared publication
Latest Publications
- Open Access
- 4 April 2025
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- Vol. 9 (3) , 300
Ferroptosis inhibition: New insights for the treatment of acute lung injury
AccScience Publishing is a publishing company based in Singapore. We have in our portfolio a range of high-quality, open-access, peer-reviewed journals and books from a broad spectrum of science, technology, biomedicine, engineering, education, social sciences and many more.
- 4 April 2025
- Published by AccScience Publishing in Eurasian Journal of Medicine and Oncology
- Vol. 9 (3) , 300
Open AccessFerroptosis inhibition: New insights for the treatment of acute lung injury
AccScience Publishing is a publishing company based in Singapore. We have in our portfolio a range of high-quality, open-access, peer-reviewed journals and books from a broad spectrum of science, technology, biomedicine, engineering, education, social sciences and many more.
- 23 August 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 336, 118730
Perilla frutescens leaf extracts alleviate acute lung injury in mice by inhibiting KAT2A
- 23 August 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 336, 118730
Perilla frutescens leaf extracts alleviate acute lung injury in mice by inhibiting KAT2A
- Top Cited PapersOpen Access
- 21 May 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 175, 116773
Exploring immune-related pathogenesis in lung injury: Providing new insights Into ALI/ARDS
- 21 May 2024
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 175, 116773
Top Cited PapersOpen AccessExploring immune-related pathogenesis in lung injury: Providing new insights Into ALI/ARDS
- Open Access
- 28 August 2023
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 264, 115392
Nephrotoxicity assessment of podophyllotoxin-induced rats by regulating PI3K/Akt/mTOR-Nrf2/HO1 pathway in view of toxicological evidence chain (TEC) concept
- 28 August 2023
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 264, 115392
Open AccessNephrotoxicity assessment of podophyllotoxin-induced rats by regulating PI3K/Akt/mTOR-Nrf2/HO1 pathway in view of toxicological evidence chain (TEC) concept
- Open Access
- 28 February 2023
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 10, 1142498
HSV: The scout and assault for digestive system tumors
More than 25% of all malignant tumors are digestive system tumors (DSTs), which mostly include esophageal cancer, gastric cancer, pancreatic cancer, liver cancer, gallbladder cancer and cholangiocarcinoma, and colorectal cancer. DSTs have emerged as one of the prominent reasons of morbidity and death in many nations and areas around the world, posing a serious threat to human life and health. General treatments such as radiotherapy, chemotherapy, and surgical resection can poorly cure the patients and have a bad prognosis. A type of immunotherapy known as oncolytic virus therapy, have recently shown extraordinary anti-tumor effectiveness. One of the viruses that has been the subject of the greatest research in this field, the herpes simplex virus (HSV), has shown excellent potential in DSTs. With a discussion of HSV-1 based on recent studies, we outline the therapeutic effects of HSV on a number of DSTs in this review. Additionally, the critical function of HSV in the detection of cancers is discussed, and some HSV future possibilities are shown.
- 28 February 2023
- Published by Frontiers Media SA in Frontiers in Molecular Biosciences
- Vol. 10, 1142498
Open AccessHSV: The scout and assault for digestive system tumors
More than 25% of all malignant tumors are digestive system tumors (DSTs), which mostly include esophageal cancer, gastric cancer, pancreatic cancer, liver cancer, gallbladder cancer and cholangiocarcinoma, and colorectal cancer. DSTs have emerged as one of the prominent reasons of morbidity and death in many nations and areas around the world, posing a serious threat to human life and health. General treatments such as radiotherapy, chemotherapy, and surgical resection can poorly cure the patients and have a bad prognosis. A type of immunotherapy known as oncolytic virus therapy, have recently shown extraordinary anti-tumor effectiveness. One of the viruses that has been the subject of the greatest research in this field, the herpes simplex virus (HSV), has shown excellent potential in DSTs. With a discussion of HSV-1 based on recent studies, we outline the therapeutic effects of HSV on a number of DSTs in this review. Additionally, the critical function of HSV in the detection of cancers is discussed, and some HSV future possibilities are shown.